SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7884414
Source:
http://linkedlifedata.com/resource/pubmed/id/7884414
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0008976
,
umls-concept:C0034656
,
umls-concept:C0087111
,
umls-concept:C0205225
,
umls-concept:C0543467
,
umls-concept:C1272689
pubmed:issue
3
pubmed:dateCreated
1995-4-7
pubmed:abstractText
To evaluate in a randomized clinical trial systemic chemoendocrine therapy used as primary (neo-adjuvant) treatment before surgery in women with primary operable breast cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycins
,
http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed-author:AshleyS ESE
,
pubmed-author:CaseySS
,
pubmed-author:CosgroveDD
,
pubmed-author:HickishT FTF
,
pubmed-author:MakrisAA
,
pubmed-author:NashA GAG
,
pubmed-author:O'BrienM EME
,
pubmed-author:PowlesT JTJ
,
pubmed-author:SacksNN
,
pubmed-author:TidyV AVA
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
547-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7884414-Adult
,
pubmed-meshheading:7884414-Aged
,
pubmed-meshheading:7884414-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:7884414-Breast Neoplasms
,
pubmed-meshheading:7884414-Chemotherapy, Adjuvant
,
pubmed-meshheading:7884414-Combined Modality Therapy
,
pubmed-meshheading:7884414-Disease-Free Survival
,
pubmed-meshheading:7884414-Female
,
pubmed-meshheading:7884414-Follow-Up Studies
,
pubmed-meshheading:7884414-Humans
,
pubmed-meshheading:7884414-Mastectomy
,
pubmed-meshheading:7884414-Methotrexate
,
pubmed-meshheading:7884414-Middle Aged
,
pubmed-meshheading:7884414-Mitomycins
,
pubmed-meshheading:7884414-Mitoxantrone
,
pubmed-meshheading:7884414-Pilot Projects
,
pubmed-meshheading:7884414-Remission Induction
,
pubmed-meshheading:7884414-Survival Rate
,
pubmed-meshheading:7884414-Tamoxifen
pubmed:year
1995
pubmed:articleTitle
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.
pubmed:affiliation
Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't